BREITMEYER JAMES B (President, CEO) reported 2 transactions at ONCTERNAL THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/5/2024ACC: 0001209191-24-000970
DirectorOfficer· President, CEO
Since Jun 2019
-55.44K
Net shares
Net seller
$27.5K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
55.44K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−50.95K
Price / share
$0.50
Trade value
$25.28K
% of position
10.3%
1/3/2024
493.99K→443.03K
Common Stock
Indirect
Shares
−4.49K
Price / share
$0.50
Trade value
$2.23K
% of position
22.5%
1/3/2024
19.91K→15.43K
Total
Net shares
−55.44K
Net value
-$27.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2024 | F · Tax Withholding | −50.95K | $0.50 | $25.28K | 10.3% | 493.99K | 443.03K |
| Common Stock Indirect | 1/3/2024 | F · Tax Withholding | −4.49K | $0.50 | $2.23K | 22.5% | 19.91K | 15.43K |
| Total | −55.44K | -$27.50K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned196.54K
Common Stock
IndirectShares owned733.00
Total
197.28K indirect197.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 196.54K | Indirect |
| Common Stock | 733.00 | Indirect |
| Total | 197.28K | 197.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported